Showing results (21-30 of 148) with videos related to
Sort By:
Pageof 15
The American Journal of Geriatric Cardiology|March 11, 2008
Monotherapy vs combination therapy for dyslipidemia in the elderlyJames ShepherdNuclear Receptor|May 29, 2007
The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balanceAlistair V W Nunn, Jimmy Bell, Philip BarterAtherosclerosis|June 13, 2003
High density lipoproteins (HDLs) and atherosclerosis; the unanswered questionsPhilip Barter, John Kastelein, Alistair Nunn, et al.The American Journal of Cardiology|April 23, 2017
Effects of Torcetrapib and Statin Treatment on ApoC-III and Apoprotein-Defined Lipoprotein Subclasses (from the ILLUMINATE Trial)John Bagdade, Philip Barter, Carmen Quiroga, et al.Lancet (London, England)|September 12, 2006
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets studyPrakash Deedwania, Philip Barter, Rafael Carmena, et al.The New England Journal of Medicine|March 10, 2005
Intensive lipid lowering with atorvastatin in patients with stable coronary diseaseJohn C LaRosa, Scott M Grundy, David D Waters, et al.European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 26, 2009
Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic reviewDiana R Chirovsky, Veronika Fedirko, Yadong Cui, et al.Archives of Internal Medicine|October 28, 2009
Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levelsSteven A Grover, Mohammed Kaouache, Lawrence Joseph, et al.Plos One|December 23, 2014
Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkersBenoit J Arsenault, Philip Barter, David A DeMicco, et al.Journal of the American College of Cardiology|December 28, 2010
Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkersBenoit J Arsenault, Philip Barter, David A DeMicco, et al.Pageof 15